Vaccine isotherapy is based on the preparation of a remedy from the agent responsible for the disorder in the patient, here the vaccine itself. Applied to Covid-19 vaccines, this approach aims to reduce post-injection reactions (fatigue, headaches, myalgias, fever) by administering a homeopathic dilution of the received vaccine. We must establish a clear framework from the outset: no published clinical trial has validated isotherapy for Covid vaccines, and health authorities do not recommend it.
Dilutions and dynamization: the pharmacotechnology behind vaccine isotherapy
The preparation of a isotherapeutic from the Covid vaccine follows the classical Hahnemannian method. The vaccine serves as the base, diluted in series to the hundredth (CH) or the fifty-thousandth (LM). Each dilution step is accompanied by dynamization through succussions.
The technical point that distinguishes vaccine isotherapy from classical homeopathy lies in the nature of the base. In unicist homeopathy, the remedy is chosen according to the total symptomatic picture of the patient. In isotherapy, the base is imposed by the causal agent, without cataloging. This distinction has practical consequences: the prescriber does not choose between several remedies; they only adjust the dilution level and the administration rhythm.
The dilutions most commonly mentioned by practitioners range between 9 CH and 30 CH. Low dilutions (9 CH) are favored in the acute phase, in the hours following the injection, while high dilutions (15 CH, 30 CH) are reserved for working on a persistent reactive terrain.
An article detailing isotherapy and homeopathy before the Covid vaccine on Else Revue describes the pre- and post-vaccination protocols used by some practitioners.
Isotherapy and Covid vaccine side effects: what the available data says
The common side effects of mRNA vaccines (pain at the injection site, fatigue, transient fever, myalgias) are well documented by pharmacovigilance agencies. French and international health authorities recommend paracetamol and clinical monitoring as the first response.
No medical database references a controlled study on isotherapy specifically applied to Covid vaccines. The testimonies reported by homeopathic practitioners or specialized pharmacies are based on individual clinical observation, without a control group or reproducible methodology.
We observe a frequent confusion between two distinct practices:
- Isotherapy in the strict sense, which uses the vaccine itself as a diluted and dynamized base, administered after the injection to mitigate reactions.
- The homeopathic protocol for vaccination support, which combines several classical remedies (Thuja occidentalis, Silicea, Arnica montana) without using the vaccine as a base.
- Homeopathic prevention before vaccination, which aims to prepare the immune terrain before the injection using foundational remedies.
Only the first falls under true isotherapy. The other two are classical homeopathic prescriptions sometimes incorrectly presented under the term isotherapy.
Regulatory obstacles and availability of Covid isotherapeutics
The manufacture of an isotherapeutic requires the vaccine base itself. For Covid vaccines, this base is not marketed as a homeopathic raw material by reference laboratories. No official pharmacopoeia lists a Covid vaccine isotherapeutic among standardized preparations.
In Belgium, pharmacists who prepared isotherapeutics from Covid vaccine vials had their stocks seized by the SPF Public Health. European regulations strictly govern the magistral preparation of homeopathic remedies, and using an mRNA vaccine as a base raises questions of traceability and pharmaceutical safety that existing frameworks do not cover.
In France, the magistral preparation of isotherapeutics remains theoretically possible in pharmacies, but the gradual disappearance of homeopathic bases since the delisting of homeopathy complicates access. Practitioners wishing to prescribe a Covid vaccine isotherapeutic must find a pharmacy willing to prepare it from the vaccine provided by the patient, which remains exceptional.
Limitations of vaccine isotherapy and precautions for healthcare professionals
The absence of clinical data necessitates caution. Several points deserve the attention of practitioners accompanying requesting patients.
- Isotherapy should never delay the conventional management of a serious side effect (myocarditis, thrombosis, anaphylactic reaction). These situations fall under medical emergencies.
- The law of effect inversion according to dose, invoked by proponents of isotherapy, has not been demonstrated for the specific components of mRNA vaccines (spike protein, lipid nanoparticles, excipients).
- The main risk is not toxicological (high dilutions no longer contain active molecules), but informational: a patient convinced that isotherapy protects them might neglect appropriate post-vaccination monitoring.
- Research in homeopathy suffers from a structural funding deficit for large-scale randomized trials, making the publication of short-term evidence of efficacy unlikely.
We recommend that practitioners frame any isotherapeutic prescription transparently with the patient, specifying the level of available evidence and maintaining conventional medical follow-up.
Vaccine isotherapy remains a practice based on ancient homeopathic principles, applied to a recent health situation. Its theoretical interest does not compensate for the lack of scientific validation. Healthcare professionals who choose to integrate it into their practice bear the responsibility of informing their patients about this reality, without substituting an unvalidated approach for the existing pharmacovigilance recommendations.